LinkedIn Profile

Access NEURONIX historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:neuronix 2747300 Dec 16th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 17th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 18th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 19th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 21st, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 22nd, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 23rd, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 24th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 25th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Dec 26th, 2017 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Dec 26th, 2017 07:22AM Dec 26th, 2017 07:22AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.